Skip to content
Screener

Ardelyx ARDX Total Current Liabilities

Total Current Liabilities at other companies

Amgen logo
AmgenAMGN
$25.5B+24.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$4.53B+6.4%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$32.85M-85.9%
AbbVie logo
AbbVieABBV
$42.1B+15.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$44.18M+74.3%
XER
Xeris Biopharma Holdings, Inc.XERS
$189.57M+99.2%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$1.2B-4.0%
Enterprise value$1.36B-0.6%
P/S2.7×-0.6×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemJune 30, 2026December 31, 2025
Current portion of operating lease liability1,5451,479
Deferred revenue6,7381,206
Accrued expenses and other current liabilities70,96347,577
Total current liabilities132,22088,605
Operating lease liability, net of current portion2,8223,641
Long-term debt251,823202,834
Deferred revenue, non-current13,69913,699
Deferred royalty obligation related to the sale of future royalties26,31725,876

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's total current liabilities?
Ardelyx (ARDX) reported total current liabilities of $132.22M in Q2 2026.
How has Ardelyx's total current liabilities changed year-over-year?
Ardelyx's total current liabilities increased by 61.8% year-over-year, from $81.72M to $132.22M.
What is the long-term trend for Ardelyx's total current liabilities?
Over 5 years (2020 to 2025), Ardelyx's total current liabilities has grown at a 25.5% compound annual growth rate (CAGR), from $28.42M to $88.61M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Ardelyx's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude